{
  "count": 93,
  "compounds": [
    {
      "slug": "5-amino-1mq",
      "name": "5-amino-1MQ",
      "url": "https://aminodesk.com/library/5-amino-1mq",
      "markdown_url": "https://aminodesk.com/library/5-amino-1mq.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/5-amino-1mq",
      "evidence_grade": "D",
      "evidence_grade_detail": "D (no human data)",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "weight",
        "longevity"
      ],
      "summary": "Not a peptide. Blocks an enzyme involved in NAD+ metabolism. Striking results in obese mice, zero published human trials, and a 40-fold spread in the doses people inject.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "adamax",
      "name": "Adamax",
      "url": "https://aminodesk.com/library/adamax",
      "markdown_url": "https://aminodesk.com/library/adamax.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/adamax",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for this modified version",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "Semax with an added carbon cage meant to carry it into the brain. No published human trial. Nearly every claim is borrowed from Semax.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "adipotide",
      "name": "Adipotide",
      "url": "https://aminodesk.com/library/adipotide",
      "markdown_url": "https://aminodesk.com/library/adipotide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/adipotide",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not approved anywhere. No compounding route. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "weight"
      ],
      "summary": "Destroys the blood vessels feeding fat tissue. Produced about 11% weight loss in monkeys and damaged the kidneys of every treated animal at the same doses.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "ahk-cu",
      "name": "AHK-Cu",
      "url": "https://aminodesk.com/library/ahk-cu",
      "markdown_url": "https://aminodesk.com/library/ahk-cu.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ahk-cu",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "Mixed",
      "legal_status_detail": "legal as a cosmetic ingredient. Not a drug and not FDA-approved to treat anything.",
      "legal_lane": "mixed",
      "goals": [
        "skin"
      ],
      "summary": "A copper peptide sold for hair growth. Everything specific to it comes from one 2007 laboratory study on follicles and cells. No human trial.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "aod-9604",
      "name": "AOD-9604",
      "url": "https://aminodesk.com/library/aod-9604",
      "markdown_url": "https://aminodesk.com/library/aod-9604.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/aod-9604",
      "evidence_grade": "B",
      "evidence_grade_detail": "B for evidence quality, with a negative result",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Compounding status has moved repeatedly; check before assuming availability.",
      "legal_lane": "none",
      "goals": [
        "weight"
      ],
      "summary": "Tested properly and failed. Its 536-person trial found no significant weight loss against placebo. Safety record was clean; the drug simply did not work.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "ara-290",
      "name": "ARA-290",
      "url": "https://aminodesk.com/library/ara-290",
      "markdown_url": "https://aminodesk.com/library/ara-290.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ara-290",
      "evidence_grade": "B",
      "evidence_grade_detail": "B. Small randomized trials in people; no large confirming trial.",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not one of the six peptides in the October 2026 policy.",
      "legal_lane": "none",
      "goals": [
        "repair"
      ],
      "summary": "An 11-amino-acid peptide tested for nerve pain in sarcoidosis. Small randomized trials were positive, but no Phase 3 trial was run and development is inactive.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "bpc-157",
      "name": "BPC-157",
      "url": "https://aminodesk.com/library/bpc-157",
      "markdown_url": "https://aminodesk.com/library/bpc-157.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/bpc-157",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "2026 policy",
      "legal_status_detail": "compounded on prescription under the October 2026 interim policy. Not FDA-approved.",
      "legal_lane": "interim",
      "goals": [
        "repair"
      ],
      "summary": "The best-known repair peptide, now legally compoundable. Almost all of its evidence is animal work, and an investigation found most of it came from a single lab.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "bpc-157-kpv",
      "name": "BPC-157 + KPV",
      "url": "https://aminodesk.com/library/bpc-157-kpv",
      "markdown_url": "https://aminodesk.com/library/bpc-157-kpv.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/bpc-157-kpv",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "outside the October 2026 policy, which allows one active ingredient per product. Not FDA-approved.",
      "legal_lane": "none",
      "goals": [
        "repair"
      ],
      "summary": "BPC-157 and KPV in one vial. Each can be compounded alone under the 2026 policy; the mixed vial cannot, and the pair is untested.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "cagrilintide",
      "name": "Cagrilintide (and CagriSema)",
      "url": "https://aminodesk.com/library/cagrilintide",
      "markdown_url": "https://aminodesk.com/library/cagrilintide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/cagrilintide",
      "evidence_grade": "B",
      "evidence_grade_detail": "B",
      "legal_status": "Investigational",
      "legal_status_detail": "investigational. Not approved; cannot be used in compounding.",
      "legal_lane": "investigational",
      "goals": [
        "weight"
      ],
      "summary": "An amylin drug that, paired with semaglutide as CagriSema, produced about 20% weight loss in a large trial. Under FDA review; the FDA says it cannot be compounded.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "cagrisema",
      "name": "CagriSema",
      "url": "https://aminodesk.com/library/cagrisema",
      "markdown_url": "https://aminodesk.com/library/cagrisema.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/cagrisema",
      "evidence_grade": "B",
      "evidence_grade_detail": "B. Large Phase 3 trials, not yet approved.",
      "legal_status": "Investigational",
      "legal_status_detail": "investigational. Under FDA review; not approved.",
      "legal_lane": "investigational",
      "goals": [
        "weight"
      ],
      "summary": "Cagrilintide and semaglutide in one weekly injection. About 20% weight loss in its main trial. Under FDA review, with no decision announced when we last checked.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "cartalax",
      "name": "Cartalax",
      "url": "https://aminodesk.com/library/cartalax",
      "markdown_url": "https://aminodesk.com/library/cartalax.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/cartalax",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not eligible for pharmacy compounding. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "repair"
      ],
      "summary": "A Russian short peptide sold for cartilage and joint support. The evidence is cell and animal work from the group that developed it.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "cerebrolysin",
      "name": "Cerebrolysin",
      "url": "https://aminodesk.com/library/cerebrolysin",
      "markdown_url": "https://aminodesk.com/library/cerebrolysin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/cerebrolysin",
      "evidence_grade": "B",
      "evidence_grade_detail": "B. Many randomized trials; independent reviews find the benefit unproven.",
      "legal_status": "Not in the US",
      "legal_status_detail": "approved in more than 50 countries. Not FDA-approved for any use.",
      "legal_lane": "not-us",
      "goals": [
        "cognition"
      ],
      "summary": "A pig-brain peptide mixture approved in over 50 countries but not the US. A Cochrane review of 1,773 stroke patients found no benefit on death and more serious adverse events.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "cjc-1295",
      "name": "CJC-1295",
      "url": "https://aminodesk.com/library/cjc-1295",
      "markdown_url": "https://aminodesk.com/library/cjc-1295.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/cjc-1295",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not eligible for pharmacy compounding.",
      "legal_lane": "none",
      "goals": [
        "muscle"
      ],
      "summary": "Keeps growth hormone elevated for days after one injection. The entire human record is a 2006 Phase 1 study that measured hormone levels, not results.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "cjc-1295-ipamorelin",
      "name": "CJC-1295 + ipamorelin",
      "url": "https://aminodesk.com/library/cjc-1295-ipamorelin",
      "markdown_url": "https://aminodesk.com/library/cjc-1295-ipamorelin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/cjc-1295-ipamorelin",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination. Each ingredient alone is graded C.",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Neither ingredient is eligible for pharmacy compounding.",
      "legal_lane": "none",
      "goals": [
        "muscle",
        "sleep"
      ],
      "summary": "The most common growth-hormone pairing. Each part raises growth hormone in short studies; the pair has never been tested together, and neither can be legally compounded.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "cjc-1295-ipamorelin-tesamorelin",
      "name": "CJC-1295 + ipamorelin + tesamorelin",
      "url": "https://aminodesk.com/library/cjc-1295-ipamorelin-tesamorelin",
      "markdown_url": "https://aminodesk.com/library/cjc-1295-ipamorelin-tesamorelin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/cjc-1295-ipamorelin-tesamorelin",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved as a blend. CJC-1295 and ipamorelin are not eligible for pharmacy compounding.",
      "legal_lane": "none",
      "goals": [
        "muscle"
      ],
      "summary": "CJC-1295, ipamorelin and tesamorelin in one vial. Three growth hormone releasers at once. Never tested together, and two of the three cannot be compounded.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "cortagen",
      "name": "Cortagen",
      "url": "https://aminodesk.com/library/cortagen",
      "markdown_url": "https://aminodesk.com/library/cortagen.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/cortagen",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not eligible for pharmacy compounding. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "A Russian short peptide sold for brain and nerve support. The evidence is cell and animal work from the group that developed it.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "dihexa",
      "name": "Dihexa",
      "url": "https://aminodesk.com/library/dihexa",
      "markdown_url": "https://aminodesk.com/library/dihexa.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/dihexa",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not approved anywhere. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "Sold for memory. No human data of any kind, and the paper describing how it was supposed to work has been retracted.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "dsip",
      "name": "DSIP",
      "url": "https://aminodesk.com/library/dsip",
      "markdown_url": "https://aminodesk.com/library/dsip.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/dsip",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Advisory committee voted against adding it to the compounding list.",
      "legal_lane": "none",
      "goals": [
        "sleep"
      ],
      "summary": "A sleep peptide from the 1970s. In July 2026 it was the only one of seven compounds an FDA advisory committee voted against allowing pharmacies to compound.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "dulaglutide",
      "name": "Dulaglutide",
      "url": "https://aminodesk.com/library/dulaglutide",
      "markdown_url": "https://aminodesk.com/library/dulaglutide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/dulaglutide",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for its approved use",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved for type 2 diabetes, prescription only. Not approved for weight loss.",
      "legal_lane": "approved",
      "goals": [
        "weight"
      ],
      "summary": "The weekly GLP-1 sold as Trulicity. Approved for type 2 diabetes, not for weight loss, and the weight lost in its trials was modest.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "eloralintide",
      "name": "Eloralintide",
      "url": "https://aminodesk.com/library/eloralintide",
      "markdown_url": "https://aminodesk.com/library/eloralintide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/eloralintide",
      "evidence_grade": "B",
      "evidence_grade_detail": "B. One strong mid-stage trial; Phase 3 results not yet in.",
      "legal_status": "Investigational",
      "legal_status_detail": "investigational. Not FDA-approved and not available by prescription.",
      "legal_lane": "investigational",
      "goals": [
        "weight"
      ],
      "summary": "A weekly amylin drug from Lilly. Up to 20% weight loss at 48 weeks in a mid-stage trial of 263 people. Still in Phase 3, so it cannot be prescribed.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "epitalon",
      "name": "Epitalon",
      "url": "https://aminodesk.com/library/epitalon",
      "markdown_url": "https://aminodesk.com/library/epitalon.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/epitalon",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "2026 policy",
      "legal_status_detail": "compounded on prescription under the October 2026 interim policy. Not FDA-approved.",
      "legal_lane": "interim",
      "goals": [
        "longevity"
      ],
      "summary": "A four-amino-acid peptide sold for longevity and telomere effects. Legally compoundable in courses since October 2026; the human evidence is old and limited.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "epitalon-mots-c",
      "name": "Epitalon + MOTS-c",
      "url": "https://aminodesk.com/library/epitalon-mots-c",
      "markdown_url": "https://aminodesk.com/library/epitalon-mots-c.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/epitalon-mots-c",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "outside the October 2026 policy, which allows one active ingredient per product. Not FDA-approved.",
      "legal_lane": "none",
      "goals": [
        "longevity"
      ],
      "summary": "Epitalon and MOTS-c in one product. Each can be compounded alone under the 2026 policy; the mixed vial cannot, and the pair is untested.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "fgl",
      "name": "FGL",
      "url": "https://aminodesk.com/library/fgl",
      "markdown_url": "https://aminodesk.com/library/fgl.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/fgl",
      "evidence_grade": "C",
      "evidence_grade_detail": "C. One human safety study; no efficacy trial.",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "A fragment of a nerve cell adhesion protein. It improved memory in rats and passed one safety study in 24 healthy men. No trial has tested whether it works in people.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "foxo4-dri",
      "name": "FOXO4-DRI",
      "url": "https://aminodesk.com/library/foxo4-dri",
      "markdown_url": "https://aminodesk.com/library/foxo4-dri.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/foxo4-dri",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "longevity"
      ],
      "summary": "A designed peptide that clears worn-out cells in aged mice. It has no human trial, no registered study and no human safety data.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "ghk-cu",
      "name": "GHK-Cu and the Glow stack",
      "url": "https://aminodesk.com/library/ghk-cu",
      "markdown_url": "https://aminodesk.com/library/ghk-cu.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ghk-cu",
      "evidence_grade": "C",
      "evidence_grade_detail": "C for topical skin use. D for injection.",
      "legal_status": "Mixed",
      "legal_status_detail": "topical is a cosmetic ingredient. Injectable is not FDA-approved and awaits FDA review.",
      "legal_lane": "mixed",
      "goals": [
        "skin",
        "repair"
      ],
      "summary": "A copper peptide with genuine evidence in skincare, where it is sold as a cosmetic. The injectable version is a different proposition and awaits FDA review.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "ghk-cu-bpc-157",
      "name": "GHK-Cu + BPC-157",
      "url": "https://aminodesk.com/library/ghk-cu-bpc-157",
      "markdown_url": "https://aminodesk.com/library/ghk-cu-bpc-157.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ghk-cu-bpc-157",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "outside the October 2026 policy. Not FDA-approved.",
      "legal_lane": "none",
      "goals": [
        "skin",
        "repair"
      ],
      "summary": "GHK-Cu and BPC-157 in one vial. Untested as a pair, and outside the 2026 policy on two counts.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "ghk-cu-kpv",
      "name": "GHK-Cu + KPV",
      "url": "https://aminodesk.com/library/ghk-cu-kpv",
      "markdown_url": "https://aminodesk.com/library/ghk-cu-kpv.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ghk-cu-kpv",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "outside the October 2026 policy. Not FDA-approved.",
      "legal_lane": "none",
      "goals": [
        "skin"
      ],
      "summary": "GHK-Cu and KPV in one vial. Untested as a pair, and outside the 2026 policy on two counts.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "ghrp-2-ghrp-6",
      "name": "GHRP-2 and GHRP-6",
      "url": "https://aminodesk.com/library/ghrp-2-ghrp-6",
      "markdown_url": "https://aminodesk.com/library/ghrp-2-ghrp-6.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ghrp-2-ghrp-6",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as research chemicals; not eligible for compounding.",
      "legal_lane": "none",
      "goals": [
        "muscle"
      ],
      "summary": "Older growth hormone releasers. They work, and they also raise cortisol, prolactin and appetite, which is why clinicians moved on from them.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "glow-blend",
      "name": "GLOW blend",
      "url": "https://aminodesk.com/library/glow-blend",
      "markdown_url": "https://aminodesk.com/library/glow-blend.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/glow-blend",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "outside the October 2026 policy, which allows one active ingredient per product. Not FDA-approved.",
      "legal_lane": "none",
      "goals": [
        "skin",
        "repair"
      ],
      "summary": "GHK-Cu, BPC-157 and TB-500 in one vial, sold for skin, hair and recovery together. No trial of the mixture exists, and a mixed vial falls outside the 2026 policy.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "glutathione",
      "name": "Glutathione (injectable)",
      "url": "https://aminodesk.com/library/glutathione",
      "markdown_url": "https://aminodesk.com/library/glutathione.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/glutathione",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "Compounded",
      "legal_status_detail": "compounded by pharmacies; not FDA-approved",
      "legal_lane": "compounded",
      "goals": [
        "skin",
        "energy"
      ],
      "summary": "The body's main antioxidant, sold as IV drips for skin and detox. Not FDA-approved, and contaminated compounded batches sent patients to hospital in 2026.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "gonadorelin",
      "name": "Gonadorelin",
      "url": "https://aminodesk.com/library/gonadorelin",
      "markdown_url": "https://aminodesk.com/library/gonadorelin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/gonadorelin",
      "evidence_grade": "C",
      "evidence_grade_detail": "C for the way it is sold. Pump therapy for a rare hormone condition has better evidence.",
      "legal_status": "Compounded",
      "legal_status_detail": "no FDA-approved product is currently marketed. Supplied by compounding pharmacies on prescription.",
      "legal_lane": "compounded",
      "goals": [
        "hormones"
      ],
      "summary": "Synthetic GnRH, sold as an add-on to testosterone therapy to protect fertility. That use has no controlled trial behind it, and the approved brands were discontinued.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "growth-hormone",
      "name": "Growth hormone (HGH)",
      "url": "https://aminodesk.com/library/growth-hormone",
      "markdown_url": "https://aminodesk.com/library/growth-hormone.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/growth-hormone",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for approved uses. Not supported for anti-aging.",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only, for approved conditions",
      "legal_lane": "approved",
      "goals": [
        "muscle"
      ],
      "summary": "The real thing, approved for deficiency and specific medical conditions. Federal law bars distributing it for anti-aging or bodybuilding, which is most of what it is sought for.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "hcg",
      "name": "HCG",
      "url": "https://aminodesk.com/library/hcg",
      "markdown_url": "https://aminodesk.com/library/hcg.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/hcg",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for approved uses. No evidence for weight loss.",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only",
      "legal_lane": "approved",
      "goals": [
        "hormones",
        "sexual"
      ],
      "summary": "Imitates the body's signal to ovulate or to produce testosterone. Approved for fertility and certain cases of low testosterone. Not approved for weight loss, despite the diet industry built on it.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "hexarelin",
      "name": "Hexarelin",
      "url": "https://aminodesk.com/library/hexarelin",
      "markdown_url": "https://aminodesk.com/library/hexarelin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/hexarelin",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not on the list of substances pharmacies may compound. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "muscle"
      ],
      "summary": "A strong growth hormone releaser in short studies, with a catch: the response fades within weeks of regular use. Also raises cortisol and prolactin. Never approved anywhere.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "humanin",
      "name": "Humanin",
      "url": "https://aminodesk.com/library/humanin",
      "markdown_url": "https://aminodesk.com/library/humanin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/humanin",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the injected peptide",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "longevity"
      ],
      "summary": "A protective peptide your own mitochondria make. Human studies measure natural levels only. Nobody has run a trial of giving it to people.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "igf-1-lr3",
      "name": "IGF-1 LR3",
      "url": "https://aminodesk.com/library/igf-1-lr3",
      "markdown_url": "https://aminodesk.com/library/igf-1-lr3.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/igf-1-lr3",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "research reagent. Not approved anywhere; no compounding route.",
      "legal_lane": "none",
      "goals": [
        "muscle"
      ],
      "summary": "A laboratory reagent sold for muscle growth. No human trials at all. The approved IGF-1 drug carries warnings for severe low blood sugar and for malignancy.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "ipamorelin",
      "name": "Ipamorelin",
      "url": "https://aminodesk.com/library/ipamorelin",
      "markdown_url": "https://aminodesk.com/library/ipamorelin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ipamorelin",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not eligible for routine pharmacy compounding, according to the sources we trust most.",
      "legal_lane": "none",
      "goals": [
        "muscle"
      ],
      "summary": "The most popular growth hormone secretagogue, usually sold with CJC-1295. Raises growth hormone reliably. Its only human trial, in post-surgical recovery, failed.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "khavinson-bioregulators",
      "name": "Khavinson short peptides (9)",
      "url": "https://aminodesk.com/library/khavinson-bioregulators",
      "markdown_url": "https://aminodesk.com/library/khavinson-bioregulators.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/khavinson-bioregulators",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for each of the nine",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not eligible for pharmacy compounding. Sold as research chemicals.",
      "legal_lane": "none",
      "goals": [
        "longevity",
        "repair",
        "hormones"
      ],
      "summary": "Nine Russian short peptides, each sold for one organ: Bronchogen, Cardiogen, Chonluten, Crystagen, Livagen, Ovagen, Pancragen, Prostamax and Testagen. No controlled human trial of any of them.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "kisspeptin",
      "name": "Kisspeptin",
      "url": "https://aminodesk.com/library/kisspeptin",
      "markdown_url": "https://aminodesk.com/library/kisspeptin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/kisspeptin",
      "evidence_grade": "B",
      "evidence_grade_detail": "B",
      "legal_status": "Investigational",
      "legal_status_detail": "investigational. No FDA-approved product.",
      "legal_lane": "investigational",
      "goals": [
        "hormones",
        "sexual"
      ],
      "summary": "The hormone that starts puberty. Has real controlled trials in IVF and in low sexual desire, though the version sold online differs from the one studied.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "klow-blend",
      "name": "KLOW blend",
      "url": "https://aminodesk.com/library/klow-blend",
      "markdown_url": "https://aminodesk.com/library/klow-blend.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/klow-blend",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "outside the October 2026 policy, which allows one active ingredient per product. Not FDA-approved.",
      "legal_lane": "none",
      "goals": [
        "skin",
        "repair"
      ],
      "summary": "The GLOW formula plus KPV: four peptides in a fixed ratio, mostly GHK-Cu by weight. Never tested as a mixture, and outside the 2026 policy.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "kpv",
      "name": "KPV",
      "url": "https://aminodesk.com/library/kpv",
      "markdown_url": "https://aminodesk.com/library/kpv.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/kpv",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "2026 policy",
      "legal_status_detail": "compounded on prescription under the October 2026 interim policy. Not FDA-approved.",
      "legal_lane": "interim",
      "goals": [
        "repair"
      ],
      "summary": "A three-amino-acid peptide taken orally or applied to skin, marketed for gut and skin inflammation. Covered by the 2026 policy, with thin human data.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "l-carnitine",
      "name": "L-carnitine (injectable)",
      "url": "https://aminodesk.com/library/l-carnitine",
      "markdown_url": "https://aminodesk.com/library/l-carnitine.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/l-carnitine",
      "evidence_grade": "B",
      "evidence_grade_detail": "B for weight loss (many trials, small effect)",
      "legal_status": "Mixed",
      "legal_status_detail": "approved for carnitine deficiency; supplement; injections for weight loss are off-label or unregulated",
      "legal_lane": "mixed",
      "goals": [
        "weight",
        "energy"
      ],
      "summary": "Approved for carnitine deficiency and sold as weight-loss shots. Dozens of trials, mostly oral, show about 1 kg of extra weight loss; the shots themselves are untested.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "larazotide",
      "name": "Larazotide",
      "url": "https://aminodesk.com/library/larazotide",
      "markdown_url": "https://aminodesk.com/library/larazotide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/larazotide",
      "evidence_grade": "B",
      "evidence_grade_detail": "B. Real trials in people; the largest was stopped for lack of effect.",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not on the list of substances pharmacies may compound.",
      "legal_lane": "none",
      "goals": [
        "repair"
      ],
      "summary": "An oral peptide tested for celiac disease and sold as a gut-repair peptide. Its Phase 3 trial was stopped in 2022 when interim results showed it was unlikely to succeed.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "lipo-c",
      "name": "Lipo-C and Lipo-C + B12",
      "url": "https://aminodesk.com/library/lipo-c",
      "markdown_url": "https://aminodesk.com/library/lipo-c.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/lipo-c",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for weight loss",
      "legal_status": "Compounded",
      "legal_status_detail": "compounded on prescription. Not an FDA-approved product.",
      "legal_lane": "compounded",
      "goals": [
        "weight",
        "energy"
      ],
      "summary": "A compounded shot of methionine, inositol and choline, usually with B12. Not a peptide. We found no controlled trial showing it causes weight loss.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "liraglutide",
      "name": "Liraglutide",
      "url": "https://aminodesk.com/library/liraglutide",
      "markdown_url": "https://aminodesk.com/library/liraglutide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/liraglutide",
      "evidence_grade": "A",
      "evidence_grade_detail": "A",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only",
      "legal_lane": "approved",
      "goals": [
        "weight"
      ],
      "summary": "The older, daily GLP-1 injection, sold as Saxenda and Victoza. About 8% average weight loss in its main trial, and the first GLP-1 with an approved generic for weight loss.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "ll-37",
      "name": "LL-37 (cathelicidin)",
      "url": "https://aminodesk.com/library/ll-37",
      "markdown_url": "https://aminodesk.com/library/ll-37.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ll-37",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "No legal route",
      "legal_status_detail": "no approved product; FDA compounding review due by February 2027",
      "legal_lane": "none",
      "goals": [
        "repair"
      ],
      "summary": "The body's own antimicrobial peptide. Tested only as a wound treatment, with one positive and one negative trial; the injectable version sold online is unstudied.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "mazdutide",
      "name": "Mazdutide",
      "url": "https://aminodesk.com/library/mazdutide",
      "markdown_url": "https://aminodesk.com/library/mazdutide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/mazdutide",
      "evidence_grade": "B",
      "evidence_grade_detail": "B",
      "legal_status": "Not in the US",
      "legal_status_detail": "not approved in the US. Approved in China for weight management and type 2 diabetes.",
      "legal_lane": "not-us",
      "goals": [
        "weight"
      ],
      "summary": "A weekly weight-loss injection approved in China in 2025. Real approval, real trials, but no route to it in the United States.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "melanotan-i",
      "name": "Melanotan I (afamelanotide, Scenesse)",
      "url": "https://aminodesk.com/library/melanotan-i",
      "markdown_url": "https://aminodesk.com/library/melanotan-i.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/melanotan-i",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for its approved use",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved for one rare condition, prescription only",
      "legal_lane": "approved",
      "goals": [
        "skin"
      ],
      "summary": "Approved as Scenesse, a clinic-inserted implant for a rare disorder that makes sunlight painful. Not approved for tanning, and the injectable powder sold online is not the approved product.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "melanotan-ii",
      "name": "Melanotan II",
      "url": "https://aminodesk.com/library/melanotan-ii",
      "markdown_url": "https://aminodesk.com/library/melanotan-ii.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/melanotan-ii",
      "evidence_grade": "C",
      "evidence_grade_detail": "C, with serious safety signals",
      "legal_status": "No legal route",
      "legal_status_detail": "gray market. Not FDA-approved and not legally compounded.",
      "legal_lane": "none",
      "goals": [
        "skin",
        "sexual"
      ],
      "summary": "Darkens skin and raises libido. Also associated with changes to moles and reports of melanoma. No legal route; FDA review due February 2027.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "methylene-blue",
      "name": "Methylene blue",
      "url": "https://aminodesk.com/library/methylene-blue",
      "markdown_url": "https://aminodesk.com/library/methylene-blue.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/methylene-blue",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for its approved use, D for cognition and longevity",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved for one condition, by injection. Products sold as supplements are not FDA-approved.",
      "legal_lane": "approved",
      "goals": [
        "cognition",
        "energy"
      ],
      "summary": "An approved prescription drug for one rare blood condition, now sold in dropper bottles for focus. Carries a boxed warning for serotonin syndrome with SSRIs and similar drugs.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "mk-677",
      "name": "MK-677 (ibutamoren)",
      "url": "https://aminodesk.com/library/mk-677",
      "markdown_url": "https://aminodesk.com/library/mk-677.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/mk-677",
      "evidence_grade": "B",
      "evidence_grade_detail": "B. Real human trials, with mixed and partly negative results.",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. On the FDA's list of substances that may present significant safety risks in compounding.",
      "legal_lane": "none",
      "goals": [
        "muscle",
        "sleep"
      ],
      "summary": "An oral drug, not a peptide, that raises growth hormone. Real trials: a little more lean mass, no gain in strength, higher blood sugar, and one trial stopped over heart failure.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "mots-c",
      "name": "MOTS-c",
      "url": "https://aminodesk.com/library/mots-c",
      "markdown_url": "https://aminodesk.com/library/mots-c.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/mots-c",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "2026 policy",
      "legal_status_detail": "compounded on prescription under the October 2026 interim policy. Not FDA-approved.",
      "legal_lane": "interim",
      "goals": [
        "energy",
        "longevity",
        "weight"
      ],
      "summary": "Encoded in mitochondrial DNA and marketed for metabolism and energy. Newly compoundable, with the human evidence still to come.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "n-acetyl-selank",
      "name": "N-acetyl Selank amidate",
      "url": "https://aminodesk.com/library/n-acetyl-selank",
      "markdown_url": "https://aminodesk.com/library/n-acetyl-selank.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/n-acetyl-selank",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for this modified version",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "Selank with both ends capped to resist breakdown. The modified version has no clinical study of its own.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "n-acetyl-semax",
      "name": "N-acetyl Semax amidate",
      "url": "https://aminodesk.com/library/n-acetyl-semax",
      "markdown_url": "https://aminodesk.com/library/n-acetyl-semax.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/n-acetyl-semax",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for this modified version",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "Semax with both ends capped to resist breakdown. The modified version has no clinical study of its own.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "nad",
      "name": "NAD+",
      "url": "https://aminodesk.com/library/nad",
      "markdown_url": "https://aminodesk.com/library/nad.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/nad",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for injected NAD+",
      "legal_status": "Compounded",
      "legal_status_detail": "long-standing compounded prescription. Not FDA-approved.",
      "legal_lane": "compounded",
      "goals": [
        "energy",
        "longevity"
      ],
      "summary": "A coenzyme central to cell metabolism. Oral precursors have human trials behind them; the injected and IV versions sold by clinics largely do not.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "oxytocin",
      "name": "Oxytocin",
      "url": "https://aminodesk.com/library/oxytocin",
      "markdown_url": "https://aminodesk.com/library/oxytocin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/oxytocin",
      "evidence_grade": "B",
      "evidence_grade_detail": "B for the nasal spray: a large, well-run trial, and it was negative. A for the approved hospital use.",
      "legal_status": "Mixed",
      "legal_status_detail": "the injection is FDA-approved for use in labor. The nasal spray is not approved and is made by compounding pharmacies.",
      "legal_lane": "mixed",
      "goals": [
        "sexual",
        "cognition"
      ],
      "summary": "Approved as a hospital drug for labor. The nasal spray sold for bonding and mood is not approved for anything, and its largest trial found no benefit.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "p21",
      "name": "P21 (P021)",
      "url": "https://aminodesk.com/library/p21",
      "markdown_url": "https://aminodesk.com/library/p21.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/p21",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "A fragment of a nerve growth factor with good mouse data on memory. No human trial, and the one independent attempt to repeat its core effect failed.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "pe-22-28",
      "name": "PE-22-28",
      "url": "https://aminodesk.com/library/pe-22-28",
      "markdown_url": "https://aminodesk.com/library/pe-22-28.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/pe-22-28",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "A seven-amino-acid peptide with antidepressant-like effects in rodents. No human trial has been completed or registered.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "peg-mgf",
      "name": "PEG-MGF",
      "url": "https://aminodesk.com/library/peg-mgf",
      "markdown_url": "https://aminodesk.com/library/peg-mgf.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/peg-mgf",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not on the list of substances pharmacies may compound. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "muscle",
        "repair"
      ],
      "summary": "A long-acting version of a growth factor that muscle makes after exercise. Everything claimed comes from cells and animals. No human trial of the injected product exists.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "pentosan-polysulfate",
      "name": "Pentosan polysulfate",
      "url": "https://aminodesk.com/library/pentosan-polysulfate",
      "markdown_url": "https://aminodesk.com/library/pentosan-polysulfate.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/pentosan-polysulfate",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for the approved bladder use. We have not graded the joint injections.",
      "legal_status": "Mixed",
      "legal_status_detail": "the capsule is FDA-approved, prescription only. Injections are not approved.",
      "legal_lane": "mixed",
      "goals": [
        "repair"
      ],
      "summary": "Not a peptide. The capsule is approved for bladder pain from interstitial cystitis and carries an eye warning with long-term use. The joint injections clinics sell are not approved.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "pinealon",
      "name": "Pinealon",
      "url": "https://aminodesk.com/library/pinealon",
      "markdown_url": "https://aminodesk.com/library/pinealon.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/pinealon",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "research chemical. No approval and no US compounding route.",
      "legal_lane": "none",
      "goals": [
        "cognition",
        "longevity"
      ],
      "summary": "A Russian three-amino-acid 'bioregulator' sold for memory and brain aging. Evidence is cell and rodent work from one research group.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "pnc-27",
      "name": "PNC-27",
      "url": "https://aminodesk.com/library/pnc-27",
      "markdown_url": "https://aminodesk.com/library/pnc-27.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/pnc-27",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Subject of an FDA consumer warning.",
      "legal_lane": "none",
      "goals": [],
      "summary": "Sold online as a cure for all cancers. The FDA warned consumers not to use it after finding bacteria in samples. It has only been studied in cells.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "progesterone",
      "name": "Progesterone",
      "url": "https://aminodesk.com/library/progesterone",
      "markdown_url": "https://aminodesk.com/library/progesterone.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/progesterone",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for its approved uses",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only",
      "legal_lane": "approved",
      "goals": [
        "hormones"
      ],
      "summary": "A hormone, not a peptide. The capsules are approved to protect the uterus during estrogen therapy after menopause and to restart absent periods. Contains peanut oil.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "pt-141",
      "name": "PT-141 (bremelanotide, Vyleesi)",
      "url": "https://aminodesk.com/library/pt-141",
      "markdown_url": "https://aminodesk.com/library/pt-141.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/pt-141",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for its approved use",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only",
      "legal_lane": "approved",
      "goals": [
        "sexual"
      ],
      "summary": "The research name for bremelanotide, approved as Vyleesi for low sexual desire in premenopausal women. Raises blood pressure briefly after each dose and can darken patches of skin.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "pt-141-oxytocin",
      "name": "PT-141 + oxytocin",
      "url": "https://aminodesk.com/library/pt-141-oxytocin",
      "markdown_url": "https://aminodesk.com/library/pt-141-oxytocin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/pt-141-oxytocin",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "Mixed",
      "legal_status_detail": "each ingredient is in an FDA-approved drug. The combination is a compounded product that the FDA has not reviewed.",
      "legal_lane": "mixed",
      "goals": [
        "sexual"
      ],
      "summary": "PT-141 and oxytocin in one product. Both ingredients are in approved drugs, but the combination has no trial and no label.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "rapamycin",
      "name": "Rapamycin (sirolimus)",
      "url": "https://aminodesk.com/library/rapamycin",
      "markdown_url": "https://aminodesk.com/library/rapamycin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/rapamycin",
      "evidence_grade": "B",
      "evidence_grade_detail": "B for longevity: one real trial, small and with a missed main goal. A for the approved uses.",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved for transplant and a rare lung disease. Longevity use is off-label.",
      "legal_lane": "approved",
      "goals": [
        "longevity"
      ],
      "summary": "A transplant drug, not a peptide, taken off-label for longevity. Its one year-long trial in healthy adults missed its main goal. Carries a boxed warning for immune suppression.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "retatrutide",
      "name": "Retatrutide",
      "url": "https://aminodesk.com/library/retatrutide",
      "markdown_url": "https://aminodesk.com/library/retatrutide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/retatrutide",
      "evidence_grade": "B",
      "evidence_grade_detail": "B",
      "legal_status": "Investigational",
      "legal_status_detail": "investigational. No legal access outside a clinical trial.",
      "legal_lane": "investigational",
      "goals": [
        "weight"
      ],
      "summary": "Eli Lilly's experimental triple-hormone injection, with strong Phase 3 results and a planned FDA filing. Available only through clinical trials right now.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "retatrutide-cagrilintide",
      "name": "Retatrutide + cagrilintide",
      "url": "https://aminodesk.com/library/retatrutide-cagrilintide",
      "markdown_url": "https://aminodesk.com/library/retatrutide-cagrilintide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/retatrutide-cagrilintide",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "no lawful route. Both ingredients are investigational drugs that cannot be prescribed or compounded.",
      "legal_lane": "none",
      "goals": [
        "weight"
      ],
      "summary": "Retatrutide and cagrilintide in one product. Two unapproved weight-loss drugs from rival companies. No trial has combined them, and neither can be prescribed.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "selank",
      "name": "Selank",
      "url": "https://aminodesk.com/library/selank",
      "markdown_url": "https://aminodesk.com/library/selank.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/selank",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not eligible for US pharmacy compounding.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "Approved in Russia as an anti-anxiety nasal spray, with small trials suggesting benzodiazepine-like effect without sedation. No Western trials and no US route.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "semaglutide",
      "name": "Semaglutide",
      "url": "https://aminodesk.com/library/semaglutide",
      "markdown_url": "https://aminodesk.com/library/semaglutide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/semaglutide",
      "evidence_grade": "A",
      "evidence_grade_detail": "A",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only",
      "legal_lane": "approved",
      "goals": [
        "weight"
      ],
      "summary": "The most studied weight-loss drug available. Sold as Wegovy and Ozempic, as a weekly injection or a daily pill. Large trials behind it and a known side-effect profile.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "semax",
      "name": "Semax",
      "url": "https://aminodesk.com/library/semax",
      "markdown_url": "https://aminodesk.com/library/semax.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/semax",
      "evidence_grade": "C",
      "evidence_grade_detail": "C",
      "legal_status": "2026 policy",
      "legal_status_detail": "compounded on prescription under the October 2026 interim policy. Not FDA-approved.",
      "legal_lane": "interim",
      "goals": [
        "cognition"
      ],
      "summary": "A nasal peptide from Russian research, now legally compoundable as a nasal spray. Marketed for focus and recovery after stroke.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "semax-selank",
      "name": "Semax + Selank",
      "url": "https://aminodesk.com/library/semax-selank",
      "markdown_url": "https://aminodesk.com/library/semax-selank.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/semax-selank",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "outside the October 2026 policy. Not FDA-approved.",
      "legal_lane": "none",
      "goals": [
        "cognition"
      ],
      "summary": "Semax and Selank in one product. Never tested together, and a mixed product falls outside the 2026 policy.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "sermorelin",
      "name": "Sermorelin",
      "url": "https://aminodesk.com/library/sermorelin",
      "markdown_url": "https://aminodesk.com/library/sermorelin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/sermorelin",
      "evidence_grade": "B",
      "evidence_grade_detail": "B",
      "legal_status": "Compounded",
      "legal_status_detail": "long-standing compounded prescription. No FDA-approved product is currently sold.",
      "legal_lane": "compounded",
      "goals": [
        "muscle",
        "sleep"
      ],
      "summary": "Signals your pituitary to release its own growth hormone rather than supplying hormone directly. Prescribed and compounded legally, with modest evidence for the uses it is marketed for.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "slu-pp-332",
      "name": "SLU-PP-332",
      "url": "https://aminodesk.com/library/slu-pp-332",
      "markdown_url": "https://aminodesk.com/library/slu-pp-332.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/slu-pp-332",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "preclinical research compound. Not approved anywhere.",
      "legal_lane": "none",
      "goals": [
        "weight",
        "energy"
      ],
      "summary": "The \"exercise pill.\" Mice ran 70% longer and obese mice lost weight. No human has been given it in a registered trial.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "snap-8",
      "name": "SNAP-8",
      "url": "https://aminodesk.com/library/snap-8",
      "markdown_url": "https://aminodesk.com/library/snap-8.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/snap-8",
      "evidence_grade": "C",
      "evidence_grade_detail": "C. Manufacturer data in people; nothing independent.",
      "legal_status": "Mixed",
      "legal_status_detail": "legal as a cosmetic ingredient. Not a drug and not FDA-approved to treat anything.",
      "legal_lane": "mixed",
      "goals": [
        "skin"
      ],
      "summary": "A cosmetic peptide in wrinkle creams. The wrinkle-reduction figure comes from the manufacturer. No independent study has tested it on its own.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "ss-31",
      "name": "SS-31 (elamipretide, Forzinity)",
      "url": "https://aminodesk.com/library/ss-31",
      "markdown_url": "https://aminodesk.com/library/ss-31.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/ss-31",
      "evidence_grade": "B",
      "evidence_grade_detail": "B",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved for Barth syndrome only (accelerated approval)",
      "legal_lane": "approved",
      "goals": [
        "energy",
        "longevity"
      ],
      "summary": "Approved in 2025 for Barth syndrome, a rare mitochondrial disease, on a 12-patient trial that missed its main goals. Sold online for energy and longevity, which have not been tested.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "survodutide",
      "name": "Survodutide",
      "url": "https://aminodesk.com/library/survodutide",
      "markdown_url": "https://aminodesk.com/library/survodutide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/survodutide",
      "evidence_grade": "B",
      "evidence_grade_detail": "B",
      "legal_status": "Investigational",
      "legal_status_detail": "investigational. Not approved in any country.",
      "legal_lane": "investigational",
      "goals": [
        "weight"
      ],
      "summary": "A weekly GLP-1 and glucagon injection with about 13% average weight loss in a 76-week Phase 3 trial. Not approved; stomach side effects were common.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "tb-500",
      "name": "TB-500",
      "url": "https://aminodesk.com/library/tb-500",
      "markdown_url": "https://aminodesk.com/library/tb-500.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/tb-500",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "2026 policy",
      "legal_status_detail": "compounded on prescription under the October 2026 interim policy. Not FDA-approved.",
      "legal_lane": "interim",
      "goals": [
        "repair"
      ],
      "summary": "Related to thymosin beta-4 and usually paired with BPC-157. Legally compoundable since October 2026; human evidence for healing is essentially absent.",
      "updated": "2026-11-17",
      "clinical_review": "completed 2026-11-14"
    },
    {
      "slug": "tesamorelin",
      "name": "Tesamorelin",
      "url": "https://aminodesk.com/library/tesamorelin",
      "markdown_url": "https://aminodesk.com/library/tesamorelin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/tesamorelin",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for its approved use",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only",
      "legal_lane": "approved",
      "goals": [
        "weight",
        "muscle"
      ],
      "summary": "The only growth-hormone-type drug with a current FDA approval. Narrowly approved to reduce excess abdominal fat in people with HIV and lipodystrophy; the fat returns if you stop.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "tesamorelin-ipamorelin",
      "name": "Tesamorelin + ipamorelin",
      "url": "https://aminodesk.com/library/tesamorelin-ipamorelin",
      "markdown_url": "https://aminodesk.com/library/tesamorelin-ipamorelin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/tesamorelin-ipamorelin",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved as a blend. Ipamorelin is not eligible for pharmacy compounding.",
      "legal_lane": "none",
      "goals": [
        "muscle",
        "weight"
      ],
      "summary": "tesamorelin and ipamorelin in one vial. One part is an approved drug for a narrow use; the other cannot be compounded. Never tested together.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "tesofensine",
      "name": "Tesofensine",
      "url": "https://aminodesk.com/library/tesofensine",
      "markdown_url": "https://aminodesk.com/library/tesofensine.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/tesofensine",
      "evidence_grade": "B",
      "evidence_grade_detail": "B. One good mid-stage trial, no completed US program.",
      "legal_status": "Investigational",
      "legal_status_detail": "not FDA-approved. No prescription product exists in the US.",
      "legal_lane": "investigational",
      "goals": [
        "weight"
      ],
      "summary": "A pill, not a peptide. About 9% weight loss in a 24-week trial, alongside raised heart rate and blood pressure. Never FDA-approved.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "testosterone",
      "name": "Testosterone",
      "url": "https://aminodesk.com/library/testosterone",
      "markdown_url": "https://aminodesk.com/library/testosterone.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/testosterone",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for its approved use",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only. Schedule III controlled substance.",
      "legal_lane": "approved",
      "goals": [
        "hormones",
        "muscle"
      ],
      "summary": "A steroid hormone, not a peptide, and a controlled substance. Approved for men with low testosterone tied to a medical condition. Raises blood pressure and can reduce fertility.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "thymalin",
      "name": "Thymalin",
      "url": "https://aminodesk.com/library/thymalin",
      "markdown_url": "https://aminodesk.com/library/thymalin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/thymalin",
      "evidence_grade": "C",
      "evidence_grade_detail": "C. Human studies exist, but they are unblinded or single-source.",
      "legal_status": "Not in the US",
      "legal_status_detail": "registered in Russia. Not FDA-approved and not available by prescription in the US.",
      "legal_lane": "not-us",
      "goals": [
        "longevity"
      ],
      "summary": "A calf-thymus extract registered as an immune drug in Russia. The longevity claim rests on one unblinded cohort from its developers that nobody has repeated.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "thymogen",
      "name": "Thymogen",
      "url": "https://aminodesk.com/library/thymogen",
      "markdown_url": "https://aminodesk.com/library/thymogen.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/thymogen",
      "evidence_grade": "C",
      "evidence_grade_detail": "C. Decades of clinical use in one country; little that meets modern trial standards.",
      "legal_status": "Not in the US",
      "legal_status_detail": "registered in Russia. Not FDA-approved.",
      "legal_lane": "not-us",
      "goals": [
        "longevity"
      ],
      "summary": "A two-amino-acid peptide registered as an immune drug in Russia since 1990. Russian evidence-based medicine sources list it as lacking proven efficacy.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "thymosin-alpha-1",
      "name": "Thymosin alpha-1",
      "url": "https://aminodesk.com/library/thymosin-alpha-1",
      "markdown_url": "https://aminodesk.com/library/thymosin-alpha-1.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/thymosin-alpha-1",
      "evidence_grade": "B",
      "evidence_grade_detail": "B",
      "legal_status": "Not in the US",
      "legal_status_detail": "approved outside the US; no lawful US route",
      "legal_lane": "not-us",
      "goals": [
        "energy",
        "longevity"
      ],
      "summary": "An immune peptide approved abroad as Zadaxin for hepatitis B. An FDA advisory committee voted 17 to 4 against allowing it to be compounded.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "thymulin",
      "name": "Thymulin",
      "url": "https://aminodesk.com/library/thymulin",
      "markdown_url": "https://aminodesk.com/library/thymulin.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/thymulin",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the injected peptide",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "longevity"
      ],
      "summary": "A thymus hormone that needs zinc to work. Human studies show zinc deficiency lowers it and zinc restores it. Injecting the peptide has no modern trial behind it.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "tirzepatide",
      "name": "Tirzepatide",
      "url": "https://aminodesk.com/library/tirzepatide",
      "markdown_url": "https://aminodesk.com/library/tirzepatide.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/tirzepatide",
      "evidence_grade": "A",
      "evidence_grade_detail": "A",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only",
      "legal_lane": "approved",
      "goals": [
        "weight"
      ],
      "summary": "Acts on two hormone receptors instead of one. Sold as Zepbound and Mounjaro. Produced some of the largest weight reductions seen in obesity trials.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "tirzepatide-bpc-157",
      "name": "Tirzepatide + BPC-157",
      "url": "https://aminodesk.com/library/tirzepatide-bpc-157",
      "markdown_url": "https://aminodesk.com/library/tirzepatide-bpc-157.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/tirzepatide-bpc-157",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "not an approved product. Tirzepatide alone is FDA-approved; the mixture is not.",
      "legal_lane": "none",
      "goals": [
        "weight"
      ],
      "summary": "Tirzepatide and BPC-157 in one product. An approved weight-loss drug mixed with an animal-tested peptide. The claim that BPC-157 eases the side effects is untested.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "vesugen",
      "name": "Vesugen",
      "url": "https://aminodesk.com/library/vesugen",
      "markdown_url": "https://aminodesk.com/library/vesugen.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/vesugen",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not eligible for pharmacy compounding. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "longevity"
      ],
      "summary": "A Russian short peptide sold for blood vessel support. The evidence is cell and animal work from the group that developed it.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "vilon",
      "name": "Vilon",
      "url": "https://aminodesk.com/library/vilon",
      "markdown_url": "https://aminodesk.com/library/vilon.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/vilon",
      "evidence_grade": "D",
      "evidence_grade_detail": "D",
      "legal_status": "No legal route",
      "legal_status_detail": "not FDA-approved. Not eligible for pharmacy compounding. Sold as a research chemical.",
      "legal_lane": "none",
      "goals": [
        "longevity"
      ],
      "summary": "A Russian short peptide sold for immune support and anti-aging. Mouse and cell studies from its developers, never reproduced by an outside laboratory.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "vip",
      "name": "VIP (aviptadil)",
      "url": "https://aminodesk.com/library/vip",
      "markdown_url": "https://aminodesk.com/library/vip.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/vip",
      "evidence_grade": "C",
      "evidence_grade_detail": "C for the nasal spray. One small series without a comparison group.",
      "legal_status": "Compounded",
      "legal_status_detail": "not FDA-approved. Pharmacies may compound it on prescription while the FDA reviews it.",
      "legal_lane": "compounded",
      "goals": [
        "repair"
      ],
      "summary": "A natural signaling peptide sold as a compounded nasal spray. The evidence for the spray is one small uncontrolled series. The intravenous drug failed its large trial.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "vitamin-b12",
      "name": "Vitamin B12 injections",
      "url": "https://aminodesk.com/library/vitamin-b12",
      "markdown_url": "https://aminodesk.com/library/vitamin-b12.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/vitamin-b12",
      "evidence_grade": "A",
      "evidence_grade_detail": "A for treating deficiency",
      "legal_status": "FDA-approved",
      "legal_status_detail": "FDA-approved, prescription only",
      "legal_lane": "approved",
      "goals": [
        "energy"
      ],
      "summary": "A vitamin, not a peptide. Approved to treat B12 deficiency in people who cannot absorb it. The label lists no use for energy or weight loss when levels are normal.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    },
    {
      "slug": "wolverine-blend",
      "name": "Wolverine blend",
      "url": "https://aminodesk.com/library/wolverine-blend",
      "markdown_url": "https://aminodesk.com/library/wolverine-blend.md",
      "api_url": "https://aminodesk.com/api/v1/compounds/wolverine-blend",
      "evidence_grade": "D",
      "evidence_grade_detail": "D for the combination",
      "legal_status": "No legal route",
      "legal_status_detail": "outside the October 2026 policy, which allows one active ingredient per product. Not FDA-approved.",
      "legal_lane": "none",
      "goals": [
        "repair"
      ],
      "summary": "BPC-157 and TB-500 mixed in one vial. Each can be compounded alone under the 2026 policy; the mixed vial cannot, and the combination has never been tested in people.",
      "updated": "2026-11-17",
      "clinical_review": "pending"
    }
  ],
  "notice": "Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL."
}